Disruption is exactly the kind of thing venture capital firm Draper Fischer Jurvetson is looking for, partner Steve Jurvetson told Fox Business in an interview with anchor Liz Claman.

“If it weren’t for some disruption in the market there would be no reason for a startup company to exist,” Jurvetson said.

Jurvetson said he looks to invest in companies that are developing technologies that will disrupt the status quo.

“If you’re competing with a large incumbent business on their playing field, you’re going to lose,” he said. “You have very little money, no one’s heard of you’re a small company, but if something’s dramatically changing like new technology or deregulation of a market or a new channel of distribution like the internet, then you have a chance as a new entrant to redefine the way the game is played.”

Some of the companies the venture capitalist thinks will be disruptive in the distant future are those that are reaching new heights with nanotechnology and synthetic biology. Synthetic biology is a new technology that seeks to develop the ability to remove the DNA from a living single-cell organism and put in artificial DNA that makes useful substances such as ethanol or chemicals of interest, Jurvetson said.

“In the distant future we are actually reengineering life forms from scratch,” he said. “We’re creating artificial animals.”